Proyectos
Project 101142365
RNA-based cancer ImmunotheraPeutics to Enhance CROssPrimming
Funder:
COMISIÓN EUROPEA
edit_calendar
Duration: from 01 October 2024 to 30 September 2029
(60 months)
Current
euro
2,411,500.00 EUR
Of European scope.